Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Interest Expenses (2022 - 2025)

Historic Interest Expenses for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $8000.0.

  • PAVmed's Interest Expenses changed N/A to $8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $67000.0, marking a year-over-year change of. This contributed to the annual value of $45000.0 for FY2024, which is 9235.99% down from last year.
  • Per PAVmed's latest filing, its Interest Expenses stood at $8000.0 for Q3 2025.
  • PAVmed's Interest Expenses' 5-year high stood at $525000.0 during Q3 2022, with a 5-year trough of $7000.0 in Q4 2024.
  • In the last 4 years, PAVmed's Interest Expenses had a median value of $26000.0 in 2025 and averaged $151000.0.
  • In the last 5 years, PAVmed's Interest Expenses tumbled by 9517.54% in 2024 and then skyrocketed by 13636.36% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Interest Expenses stood at $232000.0 in 2022, then tumbled by 91.81% to $19000.0 in 2023, then crashed by 63.16% to $7000.0 in 2024, then grew by 14.29% to $8000.0 in 2025.
  • Its Interest Expenses stands at $8000.0 for Q3 2025, versus $26000.0 for Q2 2025 and $26000.0 for Q1 2025.